In a report released on August 8, Anne Samuel from J.P. Morgan maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target of $269.00. The company’s shares closed yesterday at $239.69.
According to TipRanks, Samuel is a 4-star analyst with an average return of 22.6% and a 53.33% success rate. Samuel covers the Technology sector, focusing on stocks such as Allscripts, Health Catalyst, and Convey Holding Parent.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for IQVIA Holdings with a $265.83 average price target, implying a 10.91% upside from current levels. In a report released on July 24, SVB Securities also reiterated a Buy rating on the stock with a $256.00 price target.
IQV market cap is currently $44.7B and has a P/E ratio of 40.02.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
North Carolina-based IQVIA Holdings, Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Read More on IQV:
- J.P. Morgan Keeps Their Buy Rating on Sarepta Therapeutics (SRPT)
- J.P. Morgan Keeps Their Hold Rating on Sempra Energy (SRE)
- Enovix Stock Surges 19% on Receiving a Buy from Loop Capital
- J.P. Morgan Keeps Their Hold Rating on Huntsman (HUN)
- J.P. Morgan Sticks to Its Sell Rating for Compass Minerals International (CMP)